Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ) has shared an announcement.
Shanghai Heartcare Medical Technology Corp. Ltd. has announced its 2024 Annual General Meeting (AGM) scheduled for May 26, 2025. During the AGM, the company will consider and approve various resolutions, including the work reports of the board and supervisory committee, profit distribution plan, audited financial statements, and the re-appointment of auditors. Additionally, a special resolution will be discussed to authorize the issuance of additional shares, granting the board a general mandate to manage such issuances. These resolutions are pivotal for the company’s strategic planning and financial management, potentially impacting its market position and shareholder value.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai Heartcare Medical Technology Corp. Ltd. is a company incorporated in the People’s Republic of China, operating in the medical technology industry. The company focuses on developing and providing advanced medical solutions, particularly in the field of heart care.
YTD Price Performance: 23.92%
Average Trading Volume: 14,043
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.06B
Learn more about 6609 stock on TipRanks’ Stock Analysis page.